NEAUA Main Site  |  Past and Future Meetings
New England Section of the American Urological Association
September 10, 2020
6:00 pm - 7:30 pm
Socioeconomic Committee Panel: Lessons Learned from the COVID-19 Pandemic

Public Health and Financial Impact
Mark A. Levine, MD
Health Commissioner
State of Vermont
Burlington, VT

Clinical Impacts
William F. Santis, MD
Concord Hospital Urology
Concord, NH

EMR and Practice Management Impact
Gregory S. Adey, MD
Fore River Urology
South Portland, ME

Organizational Experience with Telemedicine in the COVID Era
Veronica Triaca, MD
Concord Hospital Urology
Concord, NH
SCIENTIFIC SESSION I: ONCOLOGY I
(8 minute presentation)
*1
The Impact of Partial versus Complete BCG Intravescial Therapy on Bladder Cancer Outcomes in High-risk Non-muscle Invasive Bladder Cancer (NMIBC): Implications for Global BCG Shortages
Michael E. Rezaee, MD, MPH1, A. Aziz Ould Ismail, MD, MS2, Chiamaka L. Okorie, BSc3, Kristine E. Lynch, PhD4, Florian R. Schroeck, MD, MS5.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2VA Medical Center, White River Junction, VT, 3Geisel School of Medicine at Dartmouth, Lebanon, NH, 4VA Salt Lake City Health Care System and University of Utah, Salt Lake City, UT, 5White River Junction VA Medical Center, White River Junction, VT.
2
WITHDRAWN
*4
Parastomal Hernia Development after Cystectomy and Ileal Conduit for Bladder Cancer: Results from the Dartmouth Ileal Conduit Enhancement (DICE) Project
Michael E. Rezaee, MD, MPH, Jenaya L. Goldway, MD, Briana Goddard, BA, William Bihrle, III, MD, Alexei Viazmenski, MD, Matthew Z. Wilson, MD, MSc, John D. Seigne, MBBCh.
Dartmouth-Hitchcock Medical Center, Lebanon, NH.
5
Surgical Site Infection in Robot-assisted Radical Cystectomy vs. Open Radical Cystectomy
Katelyn K. Johnson, MD, Kevan Ip, BA, Sara Rubino, BA, Cynthia Leung, MD, Cayce B. Nawaf, MD, Thomas V. Martin, MD, David G. Hesse, MD.
Yale University, New Haven, CT.
6
Metabolomic Evaluation of Renal Cell Carcinoma and Fat-Poor Angiomyolipoma with Magnetic Resonance Spectroscopy
Melissa Huynh, MD, Andrew Gusev, BA, Francesco Palmas, PhD, Lindsey Vandergrift, BA, Chin-Lee Wu, MD, Leo Cheng, PhD, Adam Feldman, MD, MPH
Massachusetts General Hospital, Boston, MA
7
Robot-Assisted Laparoscopic Transdiaphragmatic Right Adrenalectomy
Robin Djang, MD, John Seigne, BCh, David Finley, MD.
Dartmouth Hitchcock Medical Center, Lebanon, NH.
8
9
WITHDRAWN
10
Risk Factors for Multiple Intravesical Recurrences of Non-muscle Invasive Bladder Cancer
Andrew J. Charap, BS1, Jorge Daza, MD1, Linda Dey, MD2, Alberto Martini, MD1, John Pfail, BS1, Ashkan Mortezavi, MD2, Gunnar Steineck, MD2, Lotta Renström-Koskela, MD2, Peter Wiklund, MD PhD1, John Sfakianos, MD1.
1Icahn School of Medicine at Mount Sinai, New York, NY, 2Karolinska Institute, Stockholm, Sweden.
SCIENTIFIC SESSION II: STONES I
(8 minute presentation)
11
Risk Factors for Sepsis Following PCNL
William C. Daly, BS1, Erin Santos, PA-C2, Christopher Stockdale, MD2, Johann Ingimarsson, MD2.
1Maine Medical Center Research Institute, Center for Outcomes Research and Evaluation, Portland, ME, 2Maine Medical Center Department of Urology, Portland, ME.
12
Development of a Novel Metric to Preoperatively Estimate Flexible Ureteroscopy Operative Time: "The Stone Treatment Scale (STS)"
David W. Sobel, MD, Timothy O'Rourke, MD, Rebecca Ortiz, BA, Nicole Thomasian, BS, Philip Caffery, PhD, Christopher Tucci, MS, Gyan Pareek, MD.
Brown University, Providence, RI.
13
Renal Pelvis Pressures During Ureteroscopy Predict Pyelovenous Absorption in a Porcine Model
Jeffrey K. Twum-Ampofo, MD1, Jennifer Saunders, MS2, Marle Franco, BS3, Brian H. Eisner, MD1.
1Massachusetts General Hospital, Boston, MA, 2Boston Scientific, Boston, MA, 3Boston Scientific, Marlborough, MA.
14
Outcomes of Active Surveillance for Asymptomatic Renal Stones
Shuo-chieh Wu, MD1, Amanda R. Swanton, MD1, Kevin J. Krughoff, MD1, Benjamin M. Dropkin, MD2, Vernon M. Pais, Jr., MD1.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2Vanderbilt University Medical Center, Nashville, TN.
15
Readmission After Ureteroscopy for Patients Stented Due to Febrile UTI with Obstructing Stone
Alexander J. Bandin, MD, Benjamin Press, MD, Jeremy E. Green, BA, Adam E. Ludvigson, MD, Thomas V. Martin, MD, Piruz Motamedinia, MD.
Yale New Haven Hospital, New Haven, CT.
16
24 hour Observation through Novel Stone Observation Pathway within Emergency Department Predicts Success of Outpatient Medical Expulsive Therapy
Meredith C. Wasserman, MD MS, Siddharth Marthi, BS, David W. Sobel, MD, Edmond Godbout, PA, Chris Tucci, MS RN, Gyan Pareek, MD MS.
Brown University, Providence, RI.
17
Patterns of Opioid Prescription Post Ureteroscopy Among Members of the Endourological Society
Mohannad A. Awad, MD1, David W. Sobel, MD2, Ben H. Chew, MD3, Benjamin N. Breyer, MD4, Mark K. Plante, MD1, Kevan M. Sternberg, MD1.
1University of Vermont Medical Center, Burlington, VT, 2The Minimally Invasive Urology Institute at the Mariam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, 3University of British Columbia, Vancouver, BC, Canada, 4University of California - San Francisco, San Francisco, CA.
18
Inpatient Urologic Consultation is not Necessary to Ensure Follow up in Patients with Uncomplicated Ureterolithiasis
Meredith C. Wasserman, MD MS, David W. Sobel, MD, Siddharth Marthi, BS, Edmond Godbout, PA, Chris Tucci, MS RN, Gyan Pareek, MD MS.
Brown University, Providence, RI.
19
Risk Factors for Polymicrobial Stones in Patients Undergoing PCNL
William C. Daly, BS1, Erin Santos, PA-C2, Christopher Stockdale, MD2, Johann Ingimarsson, MD2.
1Maine Medical Center Research Institute, Center for Outcomes Research and Evaluation, Portland, ME, 2Maine Medical Center Department of Urology, Portland, ME.
20
Significant Variability in Outpatient Opioid Prescriptions by Discharge Provider following Percutaneous Nephrolithotomy (PCNL)
Timothy K. O'Rourke, Jr., MD., David W. Sobel, MD., Nicole Thomasian, BS., Christopher Tucci, MS., RN., Gyan Pareek, MS., MD.
Brown University/Rhode Island Hospital, Providence, RI.
21
The High Cost of Midnight Ureteral Stents for Obstructing Urolithiasis and Infection
David W. Sobel, MD, Timothy O'Rourke, MD, Alejandra Balen, MD, Marcelo Paiva, MPP, Martus Gn, MD, Rachel Greenberg, MD, Rebecca Ortiz, BA, Philip Caffery, PhD, Christopher Tucci, MS, Gyan Pareek, MD.
Brown University, Providence, RI.
SCIENTIFIC SESSION III: BPH/RECON
(8 minute presentation)
22
A Multi-Institutional Experience Comparing Internal Urethrotomy with Intralesional Mitomycin C for Recurrent Bladder Neck Contractures in Radiated vs. Non-Radiated Patients
Alexander Rozanski, MD1, Lawrence Zhang, BA1, Daniel Holst, MD2, Steven Copacino, BA1, Alex Vanni, MD1, Jill Buckley, MD2.
1Lahey Hospital and Medical Center, Burlington, MA, 2UC San Diego, San Diego, CA.
23
A Retrospective Comparison of 1470nmDiode Laser Enucleation and Bipolar Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Hyperplasia
Sina H.B. Monfared, BS, Annaliese Ionson, MSc, Michael Emmerling, MA, Wesley Pate, MD, Mark H. Katz, MD, David S. Wang, MD, Richard K. Babayan, MD, Shaun E.L. Wason, MD.
Boston University School of Medicine, Boston, MA.
24
A Validation Study of a Simplified Acquired Buried Penis Repair Classification System: Perioperative Complications and Outcomes
Alexander Rozanski, MD, Lawrence Zhang, BA, Jaime Cavallo, MD, Alex Vanni, MD.
Lahey Hospital and Medical Center, Burlington, MA.
25
Real-world evidence with the Prostatic Urethral Lift and Rezūm: a retrospective cohort study on the efficacy and durability in 12-month clinical outcomes
Mustufa Babar, BS, Matthew Ines, BS, Sandeep Singh, BS, Nazifa Iqbal, BA, Michael Ciatto, MD.
DSS Urology, Queens Village, NY.
26
Conservative Management of Lichen Sclerosus-induced Male Urethral Strictures: Can urethral reconstruction be safely avoided?
Alexander Rozanski, MD, Lawrence Zhang, BA, Steven Copacino, BA, Alex Vanni, MD.
Lahey Hospital and Medical Center, Burlington, MA.
27
Comparison of Magnetic Resonance Imaging to Transabdominal and Transrectal Ultrasound for Sizing of the Prostate
Samuel Helrich, BS1, Nishant Garg, MD1, Wesley Pate, MD1, Philip Barbosa, MD2, Shaun Wason, MD1.
1Boston University School of Medicine, Boston, MA, 2Beth Israel Deaconess Medical Center, Boston, MA.
28
The Robotic Buccal Mucosa Graft Ureteroplasty
Matthew J. Moynihan, MD, MPH, David Canes, MD, Alex J. Vanni, MD, Alireza Moinzadeh, MD, MHL.
Lahey Clinic, Burlington, MA.
29
Prostatic Urethral Lift: Does Age Matter?
Mohannad A. Awad, MD, Richard D. Hartnett, MD, Erin Hunt, MS4, Andrew C. Mahoney, MD.
University of Vermont Medical Center, Burlington, VT.
30
Combination Robotic Simple Prostatectomy and HoLEP for Morbidly Enlarged Prostates > 400g
Alison Levy, MD, David Canes, MD, Jessica Mandeville, MD.
Lahey Hospital and Medical Center, Burlington, MA.
31
WITHDRAWN
32
Conservative Management of Radiation-induced Male Urethral Strictures: Can urethral reconstruction be safely avoided?
Alexander Rozanski, MD, Lawrence Zhang, BA, Steven Copacino, BA, Alex Vanni, MD.
Lahey Hospital and Medical Center, Burlington, MA.
SCIENTIFIC SESSION IV: ONCOLOGY II
(8 minute presentation)
33
Evaluating the outcomes of active surveillance in Gleason Grade Group 2 Prostate cancer: Prospective results from the Canary-PASS Cohort
Adrian J. Waisman Malaret, MD1, Peter Chang, MD, MPH1, Kehao Zhu, MD4, Yingye Zheng, PhD2, Lisa Newcomb, PhD2, James D. Brooks, MD3, Atreya Dash, MD4, Peter Carroll, MD, MPH5, Cristopher P. Filson, MD6, Martin E. Gleave, MD7, Michael Liss, MD8, Frances M. Martin, MD9, Todd M. Morgan, MD10, Peter S. Nelson, MD2, Daniel W. Lin, MD4, Andrew A. Wagner, MD1.
1Beth Israel Deaconess Medical Center, Boston, MA, 2Fred Hutchinson Cancer Research Center, Seattle, WA, 3Stanford University, Standford, CA, 4University of Washington, Seattle, WA, 5University of California, San Francisco, CA, 6Emory University, Atlanta, GA, 7University of British Columbia, Voncouver, BC, Canada, 8University of Texas Health Sciences Center, San Antonio, TX, 9Urology of Virginia, Virginia Beach, VA, 10University of Michigan, Ann Arbor, MI.
34
PSA Density Velocity is the Most Important Predictor of Grade Group Progression During Prostate Cancer Active Surveillance
Andrew Gusev, BA, Florian Rumpf, BA, Dimitar Zlatev, MD, Jeffrey Twum-Ampofo, MD, Carl Ceraolo, BA, Keyan Salari, MD PhD, Douglas Dahl, MD, Matthew Wszolek, MD, Michael Blute, MD, Adam S. Feldman, MD MPH.
Massachusetts General Hospital, Boston, MA.
35
Medicaid Expansion is Associated with Increased Utilization in Palliative Treatments for Metastatic Prostate, Lung, Colon and Breast Cancer in the United States
Stephen Reese, MD1, Alexander P. Cole, MD1, Marco Paciotti, MD2, Brandon A. Mahal, MD3, Nelya Melnitchouk, MD4, Zara Cooper, MD4, Adam S. Kibel, MD5, Quoc-Dien Trinh, MD1.
1Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School,, Boston, MA, 2Department of Urology, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy, 3Department of Radiation Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, Boston, MA, 4Division of Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School,, Boston, MA, 5Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School,, Boston, MA.
*36
Is Repeat Prostate Biopsy Prior to Treatment Necessary for Active Surveillance Patients with Clinical and Radiographic Findings Suggesting Gleason Grade Progression?
Jeffrey K. Twum-Ampofo, MD, Andrew Gusev, BS, Alberto C. Pieretti, MD, Florian Rumpf, BS, Keyan Salari, MD, PhD, Matthew Wszolek, MD, Adam Feldman, MD, MPH, Douglas Dahl, MD.
Massachusetts General Hospital, Boston, MA.
37
Using preoperative pelvic floor assessment to predict early return of continence after robotic radical prostatectomy
Alison Levy, MD1, Aaron Fleishman, MPH2, Max Jackson, MD4, Kyle McAnally, BA2, Jenna Leader, PT, DPT2, Marysa Warnhoff, PT2, Adrian Waisman, MD2, Marianne Chan, MD4, Allison Kleeman, MD4, Catrina Crociani, MPH2, Andrew Wagner, MD2, Peter Chang, MD, MPH2.
1Lahey Hospital and Medical Center, Burlington, MA, 2Beth Israel Deaconess Medical Center, Boston, MA.
38
Risk Stratification by Prostate Health Index Prior to MRI-Ultrasound Fusion Targeted Biopsy
Benjamin Press, MD, Ghazal Khajir, MD, Michael S. Leapman, MD, Preston Sprenkle, MD.
Yale University School of Medicine, New Haven, CT.
39
The Impact of Pre-Treatment PSA on Risk Stratification in Men with Gleason 6 Prostate Cancer: Implications for Active Surveillance
Sina Monfared, BS1, Aaron Fleishman, MPH2, Ruslan Korets, MD2, Peter Chang, MD, MPH2, Andrew Wagner, MD2, Glenn Bubley, MD2, Irving Kaplan, MD2, Aria Olumi, MD2, Boris Gershman, MD2.
1Boston University School of Medicine, Boston, MA, 2Beth Israel Deaconess Medical Center, Boston, MA.
40
Free Hand Transperineal Prostate Biopsy Offers Equivalent Cancer Detection and Improved Antibiotic Stewardship Compared to Transrectal Ultrasound-Guided Prostate Biopsy
Christian Schaufler, BS, Ryan Daigle, BS, Carl K. Gjertson, MD, Peter C. Albertsen, MD, Benjamin T. Ristau, MD.
University of Connecticut School of Medicine, Farmington, CT.
*41
The prognostic impact of a negative confirmatory biopsy and mpMRI in men on active surveillance for prostate cancer
Keyan Salari, MD, Jeffrey Twum-Ampofo, MD, Andrew Gusev, MD, Joshua Caldwell, MD, Edouard Nicaise, BS, David Kuppermann, MD, Dimitar Zlatev, MD, Douglas Dahl, MD, Jason Efstathiou, MD, Phil, Michael Blute, MD, Anthony Zietman, MD, Adam Feldman, MD, MPH.
Massachusetts General Hospital, Boston, MA.
42
Utilization and Outcomes of Serial Prostate MRI for Prostate Cancer Active Surveillance
Andrew Gusev, BA, Jeffrey Twum-Ampofo, MD, Alberto Pieretti, MD, Carl Ceraolo, BA, Florian Rumpf, BA, Alice Yu, MD, Keyan Salari, MD PhD, Douglas Dahl, MD, Adam S. Feldman, MD MPH.
Massachusetts General Hospital, Boston, MA.
43
WITHDRAWN
SCIENTIFIC SESSION V: ED/Infertility
(8 minute presentation)
44
Efficacy and Safety of a New Oral Testosterone (TU) Formulation in Hypogonadal Men: Results from the ‘inTUne’ Trial
Ronald Swerdloff, MD1, Christina Wang, MD1, Stanton Honig, MD2, John K. Amory, MD3, James Longstreth, PhD4, Marc Gittelman, MD5, Jed Kaminetsky, MD6, Brooke Harnisch, MD7, Robert Dudley, PhD8.
1Lundquist Institute at Harbor-UCLA, Torrence, CA, 2Yale University School of Medicine, New Haven, CT, 3University of Washington, Seattle, WA, 4Longstreth & Associates, Mundelein, IL, 5South Florida Medical Research, Aventura, FL, 6Manhattan Medical Research, New York, NY, 7UConn Health, Farmington, CT, 8Clarus Therapeutics, Northbrook, IL.
45
Novel mobile-enabled point-of-care testing for comprehensive male fertility assessment
Reza Amin, PhD1, Jared Bieniek, MD2, Evelyn Neuber, PhD3.
1QRfertile, farmington, CT, 2Hartford Healthcare, Hartford, CT, 3Center for Advanced Reproductive Services, farmington, CT.
46
The effect of body mass index on clomiphene citrate therapy outcomes for hypogonadal men
Alexander Plochocki, MD, MPH1, Alexander Erbella, MD2, Erin Burns, RN3, Susan Parks, CMA3, Nicole Rossetti, RN3, Matthew Wosnitzer, MD3.
1University of Vermont Medical Center, Burlington, VT, 2Florida State University College of Medicine / Tallahassee Memorial Healthcare, Tallahassee, FL, 3Yale New Haven Health, Northeast Medical Group, Fairfield, CT.
47
Angiographic Observations Derived From CT Cavernosography
James Trussler, MD, MS1, Diana Aponte-Colon, BA2, Mohanned Alnammi, MD1, Sebastian Flacke, MD1, Andrew McCullough, MD1.
1Lahey Hospital and Medical Center, Burlington, MA, 2Tufts University School of Medicine, Boston, MA.
48
Access to Male Fertility Preservation Information and Referrals at National Cancer Institute Cancer Centers
Kenneth A. Softness, MD1, Aaron Perecman, MD4, Taylor P. Kohn, MD3, Robert J. Carrasquillo, MD1.
1Beth Israel Deaconess Medical Center, Boston, MA, 2Frank H. Netter, MD School of Medicine, New Haven, CT, 3Johns Hopkins University, Baltimore, MD.
49
Patient Desire for Disposition of Cryopreserved Sperm upon Death as a Surrogate Marker for Likelihood of Consent for Posthumous Sperm Retrieval
Dylan M. Buller, BA1, Brooke A. Harnisch, MD1, Vikram Lyall, BS1, Michael E. Goltzman, MD1, Stanton C. Honig, MD2.
1University of Connecticut, Farmington, CT, 2Yale University School of Medicine, New Haven, CT.
50
A Novel Evaluation of Medicare Reimbursement for Commonly Treated Sexual Medicine Conditions
Lael Reinstatler, MD, MPH, Martin Gross, MD.
Dartmouth Hitchcock Medical Center, Lebanon, NH.
51
Intraoperative Use of Vancomycin Paste during Penile Prosthesis Placement: Initial Outcomes
Priyanka Bearelly, MD, MPH1, Maria D’Amico, MD1, Shu Pan, MD2, Nannan Thirumavalavan, MD3, Martin Gross, MD4, Pedro Maria, MD5, Ricardo Munarriz, MD1.
1Boston University, Boston, MA, 2NorCal Urology, Walnut Creek, CA, 3Case Western Reserve University, Cleveland, OH, 4Dartmouth-Hitchcock Medical Center, Lebanon, NH, 5Montefiore Medical Center, Bronx, NY.
52
CT Cavernosography: a Patient-Centered Approach to Understanding Functional Penile Abnormalities
Diana Aponte-Colon, BS1, James Trussler, MD, MS2, Mohanned Alnammi, MD2, Sebastian Flacke, MD2, Andrew McCullough, MD2.
1Tufts University School of Medicine, Boston, MA, 2Lahey Hospital and Medical Center, Burlington, MA.
53
Penile prosthesis placement in patients with corporal fibrosis secondary to infection or priapism: Outcomes and complications
Priyanka Bearelly, MD, MPH1, Shu Pan, MD2, Dayron Rodriguez, MD, MPH3, Michael Rezaee, MD4, Michael Witthaus, MD5, Nannan Thirumavalavan, MD6, Kevin Krughoff, MD4, Martin Gross, MD4, Ricardo Munarriz, MD1.
1Boston University, Boston, MA, 2NorCal Urology, Walnut Creek, CA, 3UT Southwestern Medical Center, Dallas, TX, 4Dartmouth-Hitchcock Medical Center, Lebanon, NH, 5University of Rochester, Rochester, NY, 6Case Western Reserve University, Cleveland, OH.
54
WITHDRAWN
SCIENTIFIC SESSION VI: Stones II/Basic Science
(8 minute presentation)
55
Acute Changes in 24 Hour Lithogenic Urine Measures Intra and Peri Partum
Eileen Brandes, MD, Zita Ficko, MD, Elizabeth Johnson, MD, Vernon Pais, Jr., MD.
Dartmouth-Hitchcock Medical Center, Lebanon, NH.
56
Does CT scan after ultrasound change surgical planning for nephrolithiasis?
Adam Ludvigson, MD, Piruz Motamedinia, MD.
Yale New Haven Hospital, New Haven, CT.
57
Association of prior pregnancy with 24-hour urine composition and stone risk.
Vivian Paredes Bhushan, MS1, Marie-Therese Valovska, MD1, Vernon M. Pais, Jr., MD2.
1Dartmouth Geisel School of Medicine, Hanover, NH, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH.
58
Continued Feasibility and Success of a Non Opioid Pathway for Postoperative Pain after Ureteroscopy
Mohannad A. Awad, MD1, David W. Sobel, MD2, Nikolas Moring, MS41, Kevan M. Sternberg, MD1.
1University of Vermont Medical Center, Burlington, VT, 2The Minimally Invasive Urology Institute at the Mariam Hospital, Warren Alpert Medical School of Brown University, Providence, RI.
59
Emergency department factors that predict prolonged length of stay after stent placement for obstructing urolithiasis and infection.
Alejandra Balen, MD, David Sobel, MD, Marcelo Paiva, MPP, Timothy O'Rourke, MD, Martus Gn, MD, Rachel Greenberg, MD, Rebecca Ortiz, BA, Philip Caffery, PhD, Christopher Tucci, MSN, Gyan Pareek, MS MD.
Brown University, Providence, RI.
60
Genetically defined ancestry reveals unique prostate cancer associated polymorphisms in men of African ancestry: analysis of the ELLIPSE Prostate Cancer Cohort
Meghana S. Pagadala, BS1, Joshua A. Linscott, MD, PhD2, Hannah Carter, PhD1, Karim A. Kader, MD, PhD3, Stephen T. Ryan, MD2.
1University of California San Diego School of Medicine, San Diego, CA, 2Maine Medical Center, Portland, ME, 3University of California San Diego Health, San Diego, CA.
61
Kidney Stone Volume Measurement using Ultra-Low Dose Computed Tomography and New Software Solutions
Ohad Kott, MD1, Thomas Yi, MD2, Jorge Pereira, MD3, David Grand, MD4, Adib Karam, MD4, Derek Merck, PhD4, Scott Collins, PhD4, Simone Thavaseelan, MD5, Gyan Pareek, MD6.
1Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI, 2The Warren Alpert Medical School of Brown University, Providence, RI, 3Mount Sinai Medical Center, Miami Beach, FL, 4Rhode Island Hospital, Providence, RI, 5Rhode Island Hospital; Warren Alpert Medical School of Brown University, Providence, RI, 6Minimally Invasive Urology Institute, The Miriam Hospital; The Warren Alpert Medical School of Brown University, Providence, RI.
62
Methylation of SRD5A2 promoter predicts a better outcome for patients undergoing androgen deprivation therapy in patients with Castration Resistant Prostate Cancer
Zongwei Wang, PhD1, Tuo Deng, MD1, Shulin Wu, MD2, Xueming Lin, MD2, Zhenwei Zhang, PhD3, Chin-Lee Wu, MD2, Mary-Ellen Taplin, MD3, Aria F. Olumi, MD1.
1BIDMC, Boston, MA, 2MGH, Boston, MA, 3Dana Farber Cancer Institute, Boston, MA.
63
WITHDRAWN
64
Sendai virus as a novel oncolytic virus for urothelial carcinoma
Andrew J. Charap, BS1, John Heard, MS2, Matthew Lin, BS1, Jorge Daza, MD1, John Sfakianos, MD1, Amir Horowitz, PhD1.
1Icahn School of Medicine at Mount Sinai, New York, NY, 2SUNY Downstate College of Medicine, New York, NY.
65
Time to operating room is significantly longer if emergency department presentation occurs "after hours" for patients with pyelonephritis and obstructing stones
Timothy K. O'Rourke, Jr., MD, David W. Sobel, MD, Marcelo Paiva, M.P.P., Praveen Rajaguru, M.P.H., Christopher Tucci, MS., R.N., Gyan Pareek, MS., MD.
Brown University/Rhode Island Hospital, Providence, RI.
SCIENTIFIC SESSION VII: Female/Neuro
(8 minute presentation)
66
Surgical Management of Urethral Bulking Agent Complications in Women
Michael E. Goltzman, MD1, Richard T. Kershen, MD2.
1UConn Health, Farmington, CT, 2Tallwood Institute of Urology, Hartford Healthcare Medical Group, Hartford, CT.
67
Once-Daily Vibegron 75 mg for Overactive Bladder (OAB): Double-Blind 52-Week Results From an Extension Study of the International Phase 3 Trial (EMPOWUR)
David Staskin, MD1, Jeffrey Frankel, MD2, Susann Varano, MD3, Denise Shortino, MS4, Rachael Jankowich, RN, MSN4, Paul N Mudd, Jr., PharmD, MBA4.
1Tufts University School of Medicine, Boston, MA, 2Seattle Urology Research Center, Seattle, WA, 3Clinical Research Consulting, Milford, CT, 4Urovant Sciences, Irvine, CA.
68
Anovaginal Distance and UTI Frequency inOlder Women: Does Distance Matter?
Brooke Moore, BS, Garen Kroshian, BS, Kirstin Lee, BS, Paula Bellin, MD.
UMassMemorial Medical Center, Worcester, MA.
69
Single Surgeon Outcomes with Artificial Urinary Sphincter (AUS) implants in High-Risk Patient Population.
Wesley H. Chou, BA, Ajay K. Singla, MD.
Massachusetts General Hospital, Boston, MA.
70
Sodium Bicarbonate to Augment Lidocaine’s Intravesical Activity: A Randomized, Crossover Study
Michael E. Goltzman, MD1, Brendan Gontarz, MD1, Suzanne Roman, LPN2, Gerard Pregenzer, MD2.
1UConn Health, Farmington, CT, 2Saint Francis Hospital, Trinity Health of New England, Hartford, CT.
POSTER SESSION I
(5 minute presentation)
P1
Nocturnal-Only Voiding Diaries: A Rational Alternative to 24-Hour Diaries for Patients with Nocturia?
Thomas F. Monaghan, MD Candidate, Raymond Khargi, MD, Connelly D. Miller, MD Candidate, Christina W. Agudelo, MD Candidate, Kyle P. Michelson, MD, Syed N. Rahman, MD Candidate, Matthew R. Epstein, MD, Jeffrey P. Weiss, MD.
SUNY Downstate Health Sciences University, Brooklyn, NY.
P2
Nocturnal Urine Production is Central to the Pathogenesis of Nocturia in Patients with the Nocturnal Polyuria Syndrome
Thomas F. Monaghan, MD Candidate1, Christina W. Agudelo, MD Candidate1, Syed N. Rahman, MD Candidate1, Kyle P. Michelson, MD1, Jason M. Lazar, MD1, Karel Everaert, MD, PhD2, Jeffrey P. Weiss, MD1, Donald L. Bliwise, PhD3.
1SUNY Downstate Health Sciences University, Brooklyn, NY, 2Ghent University Hospital, Ghent, Belgium, 3Emory University School of Medicine, Atlanta, GA.
P3
A Case Study Describing Successful Treatment of Recurrent Penile Abscesses using the Carrion Cast
Lael Reinstatler, MD, MPH1, Martin Gross, MD1, Ricardo Munarriz, MD2.
1Dartmouth Hitchcock Medical Center, Lebanon, NH, USA, 2Boston University, Boston, MA.
P4
An Effective Foley Catheter Training Protocol for all Intern Residents
William J. Devan, MD, Brian Jumper, MD, Moritz Hansen, MD, Christina Gentile, MPH, Bethany Hundt, MA.
Maine Medical Center, South Portland, ME.
P5
Urolithiasis management in the early 1900s: Howard A. Kelly and the wax-tipped ureteral catheter
Timothy K. O'Rourke, Jr., MD1, Marc A. Lavine, MD2, Anthony A. Caldamone, MD1.
1Brown University/Rhode Island Hospital, Providence, RI, 2Jefferson Health, Philadelphia, PA.
P6
The Pioneering and Diverse Contributions of Leonard N. Zinman, MD to Urology
Marianne Casilla-Lennon, MD1, Stephanie Hanchuk, MD1, Alyssa Grimshaw, MS.1, Patrick Kenney, MD1, Alex J. Vanni, MD2, Jaime A. Cavallo, MD, MPHS1.
1Yale School of Medicine, New Haven, CT, 2Beth Israel Lahey Health, Burlington, MA.
*P7
Differential expression of miRNA involved in biological processes responsible for inflammation and immune response in Lichen Sclerosus Urethral Stricture Disease
Harjivan S. Kohli, MD1, Brandon Childs, MD1, Travis B. Sullivan, MS1, Artem Shevtsov, MD2, Eric Burks, MD2, Thomas Kalantzakos, BS1, Kimberly Rieger-Christ, PhD1, Alex J. Vanni, MD1.
1Lahey Hospital & Medical Center, Burlington, MA, 2Boston University School of Medicine, Boston, MA.
P8
From Focused Residency Training to Attending Practice: A Junior Attending’s Experience with Greenlight Laser Enucleation of the Prostate (GreenLEP) on Large Prostates (>80cc)
Michael E. Rezaee, MD1, Christopher D. Ortengren, MD1, Alan Yaghoubian, MD2, Michael T. Grant, MD1.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2Massachusetts General Hospital, Boston, MA.
P9
"I Only Want To See the Doctor" Comparison of Patient Satisfaction between Urology Physicians and Advanced Practice Providers
Erin Santos, PA, MPH, Kelly Ernst, FNP, CUNP, Lisa Beaule, MD, Moritz Hansen, MD, Matthew Hayn, MD, Jesse Sammon, DO.
Maine Medical Partners Urology, South Portland, ME.
P10
Modulation of TRPV4 Channel Activity by ATP in Rat and Human Urinary Bladder
Seneca D. Hutson, BSc.1, Katarina Zvarova, MD, PhD2, Peter Zvara, MD, PhD2.
1University of Vermont, Burlington, VT, 2University of Southern Denmark, Odense, Denmark.
P11
Estrogen Receptors Regulate Prostate Growth in Benign Prostatic Hyperplasia upon SRD5A2 Promoter Methylation
Christina Sharkey, BS, Sijun Liu, MD, Zongwei Wang, PhD, Aria F. Olumi, MD.
BIDMC, Boston, MA.
P12
Utilization of Capillary Electrophoresis Mass Spectrometry in the Development of a Metabolomic Signature for Prostate Cancer
Andrew Gusev, BA1, Leo L. Cheng, PhD1, Alex Buko, PhD2, Takushi Oga, PhD2, Adam S. Feldman, MD MPH1.
1Massachusetts General Hospital, Boston, MA, 2Human Metabolome Technologies, Boston, MA.
*P13
Ureteral Botulinum Toxin Attenuates Prostaglandin Expression in an Animal Model
Kevin Krughoff, MD1, Scott Palisoul, MD4, Faith Anderson, BS3, Steven Tau, BS3, Alison Young, MS3, Jason Pettus, MD2, Karen Moodie, DVM4, Matthew Havrda, PhD3, David Chavez, MD1.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2Department of Pathology, Dartmouth-Hitchcock, Lebanon, NH, 3Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Lebanon, NH, 4Geisel School of Medicine at Dartmouth, Lebanon, NH.
P14
Necrotizing Penile Shaft Infection after Compression Ring Use: A Photographic Case Report
Amanda R. Swanton, MD/PhD, Kevin J. Krughoff, MD, Gina N. Tundo, MD, Martin S. Gross, MD.
Dartmouth-Hitchcock Medical Center, Lebanon, NH
P15
The Evolving Focus on Surgeon Pregnancy by the Medical Community
Marianne Casilla-Lennon, MD, Stephanie Hanchuk, MD, Alyssa Grimshaw, MS., Justin Nguyen, MD, Benjamin Press, MD, Sisi Zheng, BA, David Kim, BA, Jaime Cavallo, MD, MPHS.
Yale School of Medicine, New Haven, CT.
POSTER SESSION II
(5 minute presentation)
P16
Established and experimental techniques to improve phalloplasty outcomes: Optimization of a hypercomplex surgery
Erin Carter, MS1, Curtis Crane, MD2, Richard Santucci, MD2.
1Boston University School of Medicine, Boston, MA, 2The Crane Center for Transgender Surgery, Austin, TX.
P17
Evaluating a Rural Transgender and Gender Diverse Population and Interest in Genital Gender Confirming Surgery
Amanda R. Swanton, MD/PhD, Ella A. Damiano, MD, John F. Nigriny, MD, Benjamin Boh, DO, MS, John H. Turco, MD, William Bihrle, III, MD, Rachel A. Moses, MD, MPH.
Dartmouth-Hitchcock Medical Center, Lebanon, NH.
P18
Autologous Dermal Fat Graft Augmentation Glansplasty for Management of Transmasculine Neo-glans Atrophy following Penile Prosthesis Placement
Rachel A. Moses, MD, MPH1, Amanda R. Swanton, MD/PhD1, Mang L. Chen, MD2.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2G.U. Recon, San Francisco, CA.
P19
Predicting Cancer Detection Rates from Multiparametric Prostate MRI: Refining the PI-RADS Categorization System
Francisco Ramos, BS1, Aaron Fleishman, MPH2, Ruslan Korets, MD2, Michael Johnson, MD2, Aria Olumi, MD2, Leo Tsai, MD, PhD2, Boris Gershman, MD2.
1Harvard Medical School, Boston, MA, 2Beth Israel Deaconess Medical Center, Boston, MA.
P20
Evaluating the AUA Guidelines: cT2b-c Grade Group 1 Prostate Cancer
Esther L. Finney, MD, Kristian D. Stensland, MD, MPH, David Canes, MD, Andrea Sorcini, MD, Alireza Moinzadeh, MD, Harras B. Zaid, MD.
Lahey Hospital and Medical Center, Burlington, MA.
P21
Transperineal Prostate Biopsy - Comparing Diagnostic Accuracy and Patient Reported Pain to Standard TRUS and MRI/US Fusion Biopsy techniques.
Aaron Berkenwald, MD1, Kristian Stensland, MD1, Colette Osborne, MAS1, Linda Tropjian, BS1, Lori-Lyn Price, MAS2, Alireza Moinzadeh, MD, MHL1, William Faust, MD1.
1Lahey, Burlington, MA, 2Tufts Medical Center, Boston, MA.
P22
Learning to Hit the Target: Improving Accuracy of Fusion Biopsy over Time at Maine Medical Center
Madeline Rutan, BA1, William C. Daly, BA1, Christina Gentile, MPH2, Moritz Hansen, MD3, Matthew Hayn, MD3, Stephen Ryan, MD4, Jesse D. Sammon, DO3.
1Tufts University School of Medicine, Boston, MA, 2Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, ME, 3Division of Urology, Maine Medical Center, Portland, ME, 4Tufts University School of Medicine, Portland, ME.
P23
A Retrospective Evaluation of a Novel Perioperative Opioid Sparing Protocol for Patients Undergoing Robotic Assisted Laparoscopic Radical Prostatectomy or Nephrectomy
David M. Krok, PharmD, Lisa Rameaka, MD, Henry Cabrera, MD, Joseph Renzulli, MD.
South County Hospital, Wakefield, RI.
P24
Effect of Treatment Status on Affective Status of Patients with Prostate Cancer: A Pilot Study
William C. Daly, BS1, Madeline C. Rutan, BS1, Paul KJ Han, MD, MA, MPH1, Christina Gentile, MPH1, Matthew Hayn, MD2, Moritz H. Hansen, MD2, Jesse D. Sammon, DO2.
1Maine Medical Center Research Institute, Center for Outcomes Research and Evaluation, Portland, ME, 2Maine Medical Center Department of Urology, Portland, ME.
P25
The Impact of Residential Segregation on Prostate Cancer Treatment and Outcomes
Samuel Helrich, BS, Michael Poulson, MD, Mark Katz, MD.
Boston University School of Medicine, Boston, MA.
P26
Comparative Effectiveness of MRI-U/S Fusion versus In-bore MRI-targeted Prostate Biopsy
Francisco Ramos, BS1, Ruslan Korets, MD2, Aaron Fleishman, MPH2, Michael Johnson, MD2, Aria Olumi, MD2, Leo Tsai, MD, PhD2, Boris Gershman, MD2.
1Harvard Medical School, Boston, MA, 2Beth Israel Deaconess Medical Center, Boston, MA.
P27
Adenocarcinoma of a Continent Urinary Conduit: A Case Report and Review of the Literature
Michael E. Goltzman, MD1, Richard T. Kershen, MD2.
1UConn Health, Farmington, CT, 2Tallwood Institute of Urology, Hartford Healthcare Medical Group, Hartford, CT.
P28
The Relationship between Health Literacy and Non-Recommended Screening for Prostate Cancer Relative to other Malignancies
Madeline Rutan, BA1, Jesse D. Sammon, DO2, David-Dan Nguyen, DES3, Kerry L. Kilbridge, MD4, Peter Herzog, MPH5, Quoc-Dien Trinh, MD5.
1Tufts University School of Medicine, Boston, MA, 2Division of Urology, Maine Medical Center, Portland, ME, 3Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, 4Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA, 5Division of Urological Surgery, Brigham and Women's Hospital, Boston, MA.
P29
Post-Prostatectomy Radiation with Long Term Follow-up: Outcomes and Changing Indications.
Ghali Lemtiri-Chlieh, MS, Alex Hennessey, MD, Ilene Staff, PhD, Peter Haddock, PhD, Max Jackson, BS, Joseph Tortora, MS, Alison Champagne, BA, Joseph Cusano, BS, Tara McLaughlin, PhD, Joseph Wagner, MD.
Hartford Hospital, Hartford, CT.
P30
Association of High-Grade Prostatic Intraepithelial Neoplasia, Atypical Small Acinar Proliferation, or Perineural Invasion with the Risk of Upgrading in Active Surveillance Cohort in the MRI-Ultrasound Fusion Biopsy Era
Ghazal Khajir, MD1, Kamyar Ghabili, MD1, Olayemi Olubowale, MD4, Michael S. Leapman, MD1, Angelique W. Levi, MD1, Peter A. Humphrey, MD, PhD1, Preston C. Sprenkle, MD1.
1Yale School of Medicine, New Haven, CT, 2Tulane University, New Orleans, LA.
AUA Course of Choice: Basic Comprehension Course
Mary Weinstein Dunn, MSN, RN, OCN, NP-C
UNC Health Care
Chapel Hill, NC

Renal Cell Carcinoma: Management of Advanced Renal Cell Carcinoma
Testicular Cancer: Evolution of a Nurse Practitioner-led Testicular Cancer Survivorship Clinic
Bladder Cancer: Optimizing Post-Operative Care and Complications
Penile Cancer: What an APP Should Know About Post-Operative Care

*Max K. Willscher Award Eligible